Found: 5
Select item for more details and to access through your institution.
Identification of 3-Oxindole Derivatives as Small Molecule HIV-1 Inhibitors Targeting Tat-Mediated Viral Transcription.
- Published in:
- Molecules, 2022, v. 27, n. 15, p. 4921, doi. 10.3390/molecules27154921
- By:
- Publication type:
- Article
Synthesis and biological evaluation of 2‐benzylaminoquinazolin‐4(3H)‐one derivatives as a potential treatment for SARS‐CoV‐2.
- Published in:
- Bulletin of the Korean Chemical Society, 2022, v. 43, n. 3, p. 412, doi. 10.1002/bkcs.12470
- By:
- Publication type:
- Article
Novel SARS‐CoV‐2 entry inhibitors, 2‐anilinoquinazolin‐4(3H)‐one derivatives, show potency as SARS‐CoV‐2 antivirals in a human ACE2 transgenic mouse model.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 6, p. 1, doi. 10.1002/jmv.28863
- By:
- Publication type:
- Article
Exploitation of a novel adjuvant for polymyxin B against multidrug-resistant Acinetobacter baumannii.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 4, p. 923, doi. 10.1093/jac/dkac445
- By:
- Publication type:
- Article
Optimization of 2-Aminoquinazolin-4-(3 H)-one Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 7, p. N.PAG, doi. 10.3390/ph15070831
- By:
- Publication type:
- Article